Centessa Pharmaceuticals plc ADR (NASDAQ: CNTA): Is It A Buying Opportunity Again?

After Hours

After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility.

Stocks Info

CNTA belongs to the Healthcare sector of the NASDAQ while operating in the Biotechnology industry. The current market capitalization of Centessa Pharmaceuticals plc ADR is $2.26B. A total of 0.92 million shares were traded on the day, compared to an average of 801.45K shares.

In the most recent transaction, HUSSAIN IQBAL J bought 6,000 shares of CNTA for 17.07 per share on Mar 17 ’25. In a previous transaction on Mar 17 ’25, CHAO DAVID M bought 7,000 shares at 17.07 per share.

Among the insiders who sold shares, Weinhoff Gregory M disposed of 11,494 shares on Feb 25 ’25 at a per-share price of $15.25. This resulted in the Chief Business Officer holding 134,021 shares of CNTA after the transaction. In another insider transaction, Weinhoff Gregory M bought 11,494 shares at $15.25 per share on Feb 25 ’25.

While price targets are rarely accurate, they tend to exert some kind of influence from time to time and are often taken into account by investors. In terms of 52-week highs and lows, CNTA has a high of $19.09 and a low of $7.75.

As of this writing, CNTA has an earnings estimate of -$0.35 per share for the current quarter. EPS was calculated based on a consensus of 4.0 estimates, with a high estimate of -$0.31 per share and a lower estimate of -$0.4.

Balance Sheet Annually/Quarterly

An organization’s balance sheet depicts the assets and liabilities it has, as well as the amount of equity invested. Investors can measure a company’s prospects by calculating its financial ratios using this information. CNTA’s latest balance sheet shows that the firm has $595.08M in Cash & Short Term Investments as of fiscal 2021. There were $75.70M in debt and $24.64M in liabilities at the time. Its Book Value Per Share was $3.79, while its Total Shareholder’s Equity was $491.55M.

Analysts Opinion

There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for CNTA is Buy with a score of 5.00.

Most Popular

Related Posts